Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseIND Approval |
First Approval Ctry. / Loc.- |
First Approval Date- |
评价SY101 注射液在中国成年男性受试者中的药代动力学、生物分布和安全性以及在患者中的成像特征的 I 期临床试验
[Translation] A Phase I clinical trial to evaluate the pharmacokinetics, biodistribution and safety of SY101 injection in Chinese adult male subjects and imaging characteristics in patients
主要目的:
(1)评价SY101注射液的安全性
次要目的:
(1)评价SY101注射液的药代动力学和生物分布特征
(2)评价SY101注射液的辐射剂量学
探索性目的:
探索患者受试者中SY101注射液显像的成像特征
[Translation] Primary objectives:
(1) Evaluate the safety of SY101 injection
Secondary objectives:
(1) Evaluate the pharmacokinetics and biodistribution characteristics of SY101 injection
(2) Evaluate the radiation dosimetry of SY101 injection
Exploratory objectives:
Explore the imaging characteristics of SY101 injection in patient subjects
100 Clinical Results associated with Shanghai Shiya Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Shanghai Shiya Pharmaceutical Technology Co., Ltd.
100 Deals associated with Shanghai Shiya Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Shanghai Shiya Pharmaceutical Technology Co., Ltd.